Organovo Holdings Stock Fundamentals
| ONVO Stock | USD 1.00 0.03 2.91% |
Organovo Holdings fundamentals help investors to digest information that contributes to Organovo Holdings' financial success or failures. It also enables traders to predict the movement of Organovo Stock. The fundamental analysis module provides a way to measure Organovo Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Organovo Holdings stock.
At this time, Organovo Holdings' Reconciled Depreciation is very stable compared to the past year. Organovo | Select Account or Indicator |
Organovo Holdings Company Return On Equity Analysis
Organovo Holdings' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Organovo Holdings Return On Equity | -1.34 |
Most of Organovo Holdings' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Organovo Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Organovo Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Organovo Holdings has a Return On Equity of -1.3407. This is 94.41% lower than that of the Biotechnology sector and 96.32% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Organovo Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Organovo Holdings's current stock value. Our valuation model uses many indicators to compare Organovo Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Organovo Holdings competition to find correlations between indicators driving Organovo Holdings's intrinsic value. More Info.Organovo Holdings is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies . At this time, Organovo Holdings' Return On Equity is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Organovo Holdings by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Organovo Holdings' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organovo Holdings' earnings, one of the primary drivers of an investment's value.Organovo Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Organovo Holdings' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Organovo Holdings could also be used in its relative valuation, which is a method of valuing Organovo Holdings by comparing valuation metrics of similar companies.Organovo Holdings is currently under evaluation in return on equity category among related companies.
Organovo Holdings Current Valuation Drivers
We derive many important indicators used in calculating different scores of Organovo Holdings from analyzing Organovo Holdings' financial statements. These drivers represent accounts that assess Organovo Holdings' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Organovo Holdings' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 53.1M | 66.5M | 32.7M | 19.1M | 21.9M | 20.8M | |
| Enterprise Value | 25.8M | 29.2M | 6.2M | 5.6M | 6.4M | 6.1M |
Organovo Fundamentals
| Return On Equity | -1.34 | ||||
| Return On Asset | -0.73 | ||||
| Operating Margin | (736.00) % | ||||
| Current Valuation | 6.55 M | ||||
| Shares Outstanding | 10.08 M | ||||
| Shares Owned By Insiders | 1.91 % | ||||
| Shares Owned By Institutions | 8.23 % | ||||
| Number Of Shares Shorted | 161.88 K | ||||
| Price To Earning | (3.67) X | ||||
| Price To Book | 1.64 X | ||||
| Price To Sales | 41.91 X | ||||
| Revenue | 370 K | ||||
| Gross Profit | (8.52 M) | ||||
| EBITDA | (17.46 M) | ||||
| Net Income | (17.26 M) | ||||
| Cash And Equivalents | 26.19 M | ||||
| Cash Per Share | 3.01 X | ||||
| Total Debt | 1.8 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 20.99 X | ||||
| Book Value Per Share | 0.63 X | ||||
| Cash Flow From Operations | (12.41 M) | ||||
| Short Ratio | 1.19 X | ||||
| Earnings Per Share | (2.16) X | ||||
| Target Price | 8.55 | ||||
| Number Of Employees | 18 | ||||
| Beta | 0.9 | ||||
| Market Capitalization | 10.08 M | ||||
| Total Asset | 20.31 M | ||||
| Retained Earnings | (325 M) | ||||
| Working Capital | 13.38 M | ||||
| Current Asset | 63.65 M | ||||
| Current Liabilities | 4.49 M | ||||
| Net Asset | 20.31 M |
About Organovo Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Organovo Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Organovo Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Organovo Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 603.8 K | 645.2 K | |
| Total Revenue | 425.5 K | 404.2 K | |
| Cost Of Revenue | 263.7 K | 250.5 K | |
| Stock Based Compensation To Revenue | 1.20 | 1.14 | |
| Sales General And Administrative To Revenue | 28.25 | 16.58 | |
| Research And Ddevelopement To Revenue | 2.87 | 2.73 | |
| Capex To Revenue | (0.30) | (0.31) | |
| Revenue Per Share | 0.55 | 0.43 | |
| Ebit Per Revenue | (7.79) | (8.17) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Organovo Holdings Piotroski F Score and Organovo Holdings Altman Z Score analysis. To learn how to invest in Organovo Stock, please use our How to Invest in Organovo Holdings guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Organovo Stock analysis
When running Organovo Holdings' price analysis, check to measure Organovo Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organovo Holdings is operating at the current time. Most of Organovo Holdings' value examination focuses on studying past and present price action to predict the probability of Organovo Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organovo Holdings' price. Additionally, you may evaluate how the addition of Organovo Holdings to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Organovo Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organovo Holdings. If investors know Organovo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organovo Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Revenue Per Share 0.027 | Quarterly Revenue Growth (0.96) | Return On Assets (0.73) | Return On Equity (1.34) |
The market value of Organovo Holdings is measured differently than its book value, which is the value of Organovo that is recorded on the company's balance sheet. Investors also form their own opinion of Organovo Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organovo Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organovo Holdings' market value can be influenced by many factors that don't directly affect Organovo Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organovo Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organovo Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organovo Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.